Avril Jiao
Co-Founder, COO at Magic Lifescience- Claim this Profile
Click to upgrade to our gold package
for the full feature experience.
-
English Full professional proficiency
-
Mandarin Native or bilingual proficiency
Topline Score
Bio
Credentials
-
United Kingdom Chartered Engineer (CEng)
Institution of Chemical Engineers (IChemE)May, 2018- Nov, 2024 -
Project Management Professional (PMP)
Project Management InstituteJul, 2017- Nov, 2024 -
Level 2 Awards on Wine and Spirit
WSET — Wine & Spirit Education TrustSep, 2014- Nov, 2024
Experience
-
MagIC Lifescience
-
United States
-
Medical Equipment Manufacturing
-
1 - 100 Employee
-
Co-Founder, COO
-
Mar 2021 - Present
• A venture-backed medical device start-up to commercialize on-chip PCR rapid molecular diagnostic platform. • A venture-backed medical device start-up to commercialize on-chip PCR rapid molecular diagnostic platform.
-
-
-
The 21 Fund
-
United States
-
Higher Education
-
1 - 100 Employee
-
Investor
-
Feb 2021 - Aug 2022
• A $2M seed fund building and investing in the next generation of Stanford Graduate School of Business (GSB) startups. • Our mission is to be the most hands-on and value-add investor to every GSB ‘21 founder. • A $2M seed fund building and investing in the next generation of Stanford Graduate School of Business (GSB) startups. • Our mission is to be the most hands-on and value-add investor to every GSB ‘21 founder.
-
-
-
Johnson & Johnson
-
United States
-
Hospitals and Health Care
-
700 & Above Employee
-
Digital Marketing Manager
-
Jun 2020 - Aug 2020
• Selected to join the J&J IRDP global leadership program • Responsible for the cross-channel digital marketing strategy for Solid Tumor Business Unit • Designed and managed the virtual representative program for Zytiga strategy in China • Selected to join the J&J IRDP global leadership program • Responsible for the cross-channel digital marketing strategy for Solid Tumor Business Unit • Designed and managed the virtual representative program for Zytiga strategy in China
-
-
-
ZhenFund 真格基金
-
China
-
Venture Capital and Private Equity Principals
-
1 - 100 Employee
-
Healthcare Investor
-
Jun 2019 - Aug 2019
• Evaluated 30+ healthcare start-ups at a very well-known Angle investment fund in China. Projects ranging from pharmaceutical/biotech drug, medical devices, AI imaging platform to hospital electronic record system and physiotherapy clinics. • Sourced deals, including preparing in-depth opportunity landscapes, attending scientific and partnering conferences, and networking with biotech, venture capitalists, life sciences incubators and academia. • Conducted due diligence by… Show more • Evaluated 30+ healthcare start-ups at a very well-known Angle investment fund in China. Projects ranging from pharmaceutical/biotech drug, medical devices, AI imaging platform to hospital electronic record system and physiotherapy clinics. • Sourced deals, including preparing in-depth opportunity landscapes, attending scientific and partnering conferences, and networking with biotech, venture capitalists, life sciences incubators and academia. • Conducted due diligence by evaluating patent and literature paper from data room, interviewing funding teams and industry key opinion leaders (KOL). Successfully led 1 project pass firm’s Investment Committee and issued a term sheet. Show less • Evaluated 30+ healthcare start-ups at a very well-known Angle investment fund in China. Projects ranging from pharmaceutical/biotech drug, medical devices, AI imaging platform to hospital electronic record system and physiotherapy clinics. • Sourced deals, including preparing in-depth opportunity landscapes, attending scientific and partnering conferences, and networking with biotech, venture capitalists, life sciences incubators and academia. • Conducted due diligence by… Show more • Evaluated 30+ healthcare start-ups at a very well-known Angle investment fund in China. Projects ranging from pharmaceutical/biotech drug, medical devices, AI imaging platform to hospital electronic record system and physiotherapy clinics. • Sourced deals, including preparing in-depth opportunity landscapes, attending scientific and partnering conferences, and networking with biotech, venture capitalists, life sciences incubators and academia. • Conducted due diligence by evaluating patent and literature paper from data room, interviewing funding teams and industry key opinion leaders (KOL). Successfully led 1 project pass firm’s Investment Committee and issued a term sheet. Show less
-
-
-
Pfizer
-
United States
-
Pharmaceutical Manufacturing
-
700 & Above Employee
-
Senior Manager, Portfolio and Project Management
-
Nov 2017 - Jun 2019
• Appointed as the central point of contact for China Essential Health development portfolio, with pipeline worth $15bn market value. • Led scientific and strategic assessments and cross-functional due diligence reviews: for projects coming from global pipeline and external commercial deals with the BD team. Then define areas of interest and to develop and execute the partnering strategy for those areas. • Managed the Biosimilars (Bevacizumab, Trastuzumab, Adalimumab) end-to-end… Show more • Appointed as the central point of contact for China Essential Health development portfolio, with pipeline worth $15bn market value. • Led scientific and strategic assessments and cross-functional due diligence reviews: for projects coming from global pipeline and external commercial deals with the BD team. Then define areas of interest and to develop and execute the partnering strategy for those areas. • Managed the Biosimilars (Bevacizumab, Trastuzumab, Adalimumab) end-to-end development life cycle. Accountable for resource distribution, pipeline prioritization, and milestone delivery, by leveraging cross-functional experts from China, Australia, the UK and US. Show less • Appointed as the central point of contact for China Essential Health development portfolio, with pipeline worth $15bn market value. • Led scientific and strategic assessments and cross-functional due diligence reviews: for projects coming from global pipeline and external commercial deals with the BD team. Then define areas of interest and to develop and execute the partnering strategy for those areas. • Managed the Biosimilars (Bevacizumab, Trastuzumab, Adalimumab) end-to-end… Show more • Appointed as the central point of contact for China Essential Health development portfolio, with pipeline worth $15bn market value. • Led scientific and strategic assessments and cross-functional due diligence reviews: for projects coming from global pipeline and external commercial deals with the BD team. Then define areas of interest and to develop and execute the partnering strategy for those areas. • Managed the Biosimilars (Bevacizumab, Trastuzumab, Adalimumab) end-to-end development life cycle. Accountable for resource distribution, pipeline prioritization, and milestone delivery, by leveraging cross-functional experts from China, Australia, the UK and US. Show less
-
-
-
GSK
-
United Kingdom
-
Pharmaceutical Manufacturing
-
700 & Above Employee
-
Portfolio and Project Manager
-
Aug 2015 - Nov 2017
• Managed China cardiovascular portfolio including 9 projects. • Supervised phase I&III clinical trials in 30 hospitals and coordinated multifunctional matrix team to submit registration dossier for two firstclass new medicines to the China Food and Drug Administration (CFDA) in the year between 2016-2017.
-
-
R&D Senior Process Engineer
-
Nov 2014 - Aug 2015
• Assembled and manged 3 clinical batches in the pilot plant under Current Good Manufacturing Practice (cGMP).
-
-
R&D Process Engineer
-
Jan 2013 - Oct 2014
• Invented biocatalyst selection technology for GSK’s second-generation antibiotic to increase 10% product throughput. • Received 2014 GSK Exceptional Science Award from the CEO, followed by a fast promotion and 1,000 FTSE-GSK ordinary shares.
-
-
Education
-
Stanford University Graduate School of Business
Master of Business Administration - MBA -
Imperial College London
Bachelor and Master of Engineering (MEng), Chemical Engineering -
Wimbledon High School GDST
A level
Community
